Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant ITGAL (Efalizumab Biosimilar) antibody

The Rabbit Chimeric anti-ITGAL (Efalizumab Biosimilar) antibody has been validated for BR and FACS. It is suitable to detect ITGAL (Efalizumab Biosimilar) in samples from Human.
Catalog No. ABIN5668045

Quick Overview for Recombinant ITGAL (Efalizumab Biosimilar) antibody (ABIN5668045)

Target

ITGAL (Efalizumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 1
  • 1
  • 1
  • 1
Rabbit

Clonality

  • 2
  • 2
Chimeric

Conjugate

  • 4
This ITGAL (Efalizumab Biosimilar) antibody is un-conjugated

Application

Blocking Reagent (BR), Flow Cytometry (FACS)

Clone

Hu1124
  • Purpose

    Anti-CD11a [hu1124 (Efalizumab)], Rabbit IgG, kappa

    Specificity

    Binds to human LFA-1.

    Characteristics

    Original Species of Ab: Human

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Purity

    > 98 % as determined by SDS-PAGE

    Endotoxin Level

    Endotoxin is < 1.0 EU/mg as determined by the LAL method

    Immunogen

    Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

    Isotype

    IgG kappa
  • Application Notes

    Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.

    Comment

    This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    ITGAL (Efalizumab Biosimilar)

    Target Type

    Biosimilar

    Background

    LFA-1, integrin alpha L

    UniProt

    P20701
You are here:
Chat with us!